Status:

UNKNOWN

Drug Eluting Balloon for Treatment of Unstable Angina

Lead Sponsor:

Yun Dai Chen

Conditions:

Angina, Unstable

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

This study was to investigate the effect and safety of drug eluting balloon combined for treatment of unstable angina.

Detailed Description

Patients with unstable angina were randomized to drug eluting stent only or drug eluting balloon group. Angiographic follow-up was performed after 12 months. The primary endpoints were late lumen loss...

Eligibility Criteria

Inclusion

  • Patients \> 18, \< 80 years old, with unstable angina
  • Single-vessel or double-vessel disease
  • Length of target lesion \< 25mm
  • Diameter of target vessel \>2.5mm, \< 3.5mm

Exclusion

  • Left main disease
  • Chronic total occlusion
  • Severe Tortuosity
  • Heavy calcification
  • Severe liver failure, moderate or severe kidney failure
  • Malignant disease
  • Active infectious disease
  • Pregnancy or breastfeeding

Key Trial Info

Start Date :

November 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT02760732

Start Date

November 1 2015

End Date

August 1 2018

Last Update

November 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The General Hospital of PLA

Beijing, Beijing Municipality, China, 100853